Class 3 FMD drug alert, action within 5 days, Glaxo Wellcome UK Ltd t/a GSK, beconase aqueous nasal spray

Manufacturers warn that, upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED.’ Although there is no risk to product quality, any remaining stock should be quarantined and returned.


Medicines and Healthcare products Regulatory Agency